(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

OpenAI Expects $70 Billion in Annualized Revenue by End of 2026
18:11

Goldman’s Top Leaders Set to Score More Than $500 Million With Special Bonus
19:53

SpaceX in Talks to Borrow $40 Billion to Buy Nvidia Chips
18:06